Alzheimer's Disease Scientific Working Group

 

Co-Chairs

Estimand Workstream

  • James Bell (Boehringer-Ingelheim)
  • Angelika Caputo (Novartis)
  • Paul Delmar (Roche)
  • Michael Donohue (USC)
  • David Li (Pfizer)
  • Hong Liu-Seifert (Eli Lilly)
  • Howard Mackey (Genentech)
  • Fabian Model (Roche) +
  • Peter Quarg (Novartis)
  • Ying Zhu (Biogen)
Endpoints in Early AD Workstream

  • Angelika Caputo (Novartis)
  • Paul Delmar (Roche)
  • Mike Donohue (USC)
  • Suzanne Hendrix (Pentara)
  • Nan Hu (Genentech) 
  • Pilar Lim (Janssen)
  • Howie Mackey (Genentech) +
  • Akiko Okamoto (Janssen)
  • Melissa Anna Maria Pugh (Lilly)
  • Nandini Raghavan (Janssen)
  • Ron Thomas (UCSD)
Disease Modification Workstream
  • Scott Andersen (Eli Lilly)
  • Richard Entsuah (Merck) +
  • Wen Li (Merck)
  • Hong Liu-Seifert (Eli Lilly) +
  • Mike Rabbia (Genentech)
  • Jennifer Schumi (AstraZeneca)
  • Ying Tian (Biogen)
+ indicates co-lead